ZDRAVESKI ZORAN

CIK 00017412852 companiesWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001741285

Recent Transactions

33 trades

Award
TScan Therapeutics, Inc.$TCRX
Stock Option (Right to Buy)
2026-01-20+350,000→ 350,000 total
Award
TScan Therapeutics, Inc.$TCRX
Stock Option (Right to Buy)
2025-01-03+250,000→ 250,000 total
Exercise/Conversion
TScan Therapeutics, Inc.$TCRX
Voting Common Stock
2024-08-23$1.81/sh+13,125→ 105,236 total
Sale
TScan Therapeutics, Inc.$TCRX
Voting Common Stock
2024-08-23$5.78/sh−164,686→ 4,716 total
Exercise/Conversion
TScan Therapeutics, Inc.$TCRX
Voting Common Stock
2024-08-23$4.85/sh+54,895→ 67,111 total
Exercise/Conversion
TScan Therapeutics, Inc.$TCRX
Stock Option (Right to Buy)
2024-08-23−64,166→ 365,834 total
Exercise/Conversion
TScan Therapeutics, Inc.$TCRX
Voting Common Stock
2024-08-23$3.27/sh+25,000→ 92,111 total
Exercise/Conversion
TScan Therapeutics, Inc.$TCRX
Stock Option (Right to Buy)
2024-08-23−54,895→ 30,105 total
Exercise/Conversion
TScan Therapeutics, Inc.$TCRX
Stock Option (Right to Buy)
2024-08-23−13,125→ 21,875 total
Exercise/Conversion
TScan Therapeutics, Inc.$TCRX
Voting Common Stock
2024-08-23$2.49/sh+64,166→ 169,402 total
Exercise/Conversion
TScan Therapeutics, Inc.$TCRX
Stock Option (Right to Buy)
2024-08-23−25,000→ 25,000 total
Award
TScan Therapeutics, Inc.$TCRX
Stock Option (Right to Buy)
2024-01-12+52,500→ 52,500 total
Award
TScan Therapeutics, Inc.$TCRX
Stock Option (Right to Buy)
2023-06-13+430,000→ 430,000 total
Award
TScan Therapeutics, Inc.$TCRX
Stock Option (Right to Buy)
2023-02-02+35,000→ 35,000 total
Award
TScan Therapeutics, Inc.$TCRX
Stock Option (Right to Buy)
2022-07-25+50,000→ 50,000 total
Award
TScan Therapeutics, Inc.$TCRX
Stock Option (Right to Buy)
2022-01-18+85,000→ 85,000 total
Purchase
TScan Therapeutics, Inc.$TCRX
Voting Common Stock
2021-09-23$7.48/sh+4,716→ 4,716 total
Award
TScan Therapeutics, Inc.$TCRX
Stock Option (right to buy)
2021-09-07+150,000→ 150,000 total
Award
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2021-02-11+67,700→ 67,700 total
Award
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2020-02-10+60,000→ 60,000 total
Sale
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2019-12-24$16.00/sh−7,902→ 133,010 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2019-12-24−820→ 16,856 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2019-12-24$7.71/sh+820→ 140,912 total
Sale
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2019-12-24$16.00/sh−7,902→ 128,009 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2019-12-23−9→ 17,676 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2019-12-23−4,172→ 129,342 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2019-12-23$9.49/sh+4,172→ 144,273 total
Sale
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2019-12-23$16.03/sh−4,181→ 135,911 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2019-12-23$7.71/sh+9→ 140,101 total
Sale
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2019-12-23$16.03/sh−4,181→ 140,092 total
Award
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2019-02-05+80,000→ 80,000 total
Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2018-06-25+4,643→ 140,092 total
Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Series C Preferred Stock
2018-06-25−12,000→ 0 total

Companies

Recent Filings

Address

C/O TSCAN THERAPEUTICS, INC. 830 WINTER STREET

WALTHAM, MA, 02451

View on SEC.gov